- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Board Meeting, 30-01-2026: Outcome of Board Meeting
30-01-2026 | 08:07 pm
30-01-2026 | 08:07 pm
Glenmark Pharma's board approved consolidated Q3 & 9M financial results. Q3 revenue hit ₹3,900.62 Cr, with net profit at ₹403.23 Cr. Nine-month net profit was ₹1,060.63 Cr, impacted by a ₹177.89 Cr charge for New Labour Codes.
No comments yet. Be the first to comment!